Court Case Questions Drug Patent Acquisition Practices
By Editor • August 31, 2026 • 1 min read
As the battle unfolds between a major health insurer and biotech giant Amgen, the focus sharpens on the ethical implications of drug patent acquisitions.
This litigation could redefine how pharmaceutical patents are scrutinized, especially as critics argue these maneuvers keep drug prices artificially high.
Notably, the Federal Trade Commission has sided with consumers, highlighting significant antitrust concerns regarding these practices.
Source: www.statnews.com
